TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates

15 5 2023 07:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in the JMP Securities 2023 Life Sciences Conference

09 5 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

03 5 2023 15:05:01 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

27 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as Chief Medical Officer of Terns Oncology

27 3 2023 07:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Provides Program Updates and Announces Participation at Upcoming March Investor Conferences

02 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference

02 2 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at B. Riley Securities’ 3rd Annual Oncology Conference

12 1 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Highlight 2023 Priorities and Clinical Milestones at the 41st Annual J.P. Morgan Healthcare Conference

05 1 2023 15:05:00 提供 Nasdaq GlobeNewswire

Terns Announces Closing of Public Offering of Shares of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

23 12 2022 15:05:00 提供 Nasdaq GlobeNewswire

Terns Announces Pricing of $75 Million Public Offering

20 12 2022 18:39:56 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

20 12 2022 07:05:00 提供 Nasdaq GlobeNewswire

Terns Announces Proposed Public Offering

19 12 2022 15:31:04 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the 2022 JMP Securities Hematology and Oncology Summit

01 12 2022 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights

09 11 2022 15:05:01 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals Highlights Results from Phase 1 Clinical Trial of TERN-501 at AASLD The Liver Meeting® 2022

04 11 2022 07:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present Positive Clinical Data in NASH at AASLD The Liver Meeting® 2022

26 10 2022 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the H. C. Wainwright 6th Annual NASH Investor Conference

11 10 2022 15:05:00 提供 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 9 2022 15:05:00 提供 Nasdaq GlobeNewswire

Terns Announces $65 Million Oversubscribed Offering

12 8 2022 07:00:00 提供 Nasdaq GlobeNewswire